Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.19.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2019
Jun. 30, 2018
NET CASH PROVIDED BY OPERATING ACTIVITIES $ 4,319 $ 4,846
INVESTING ACTIVITIES    
Purchase of medical equipment, property and equipment (7,893) (2,743)
Proceeds from sale of medical equipment, property and equipment 1,333 1,720
NET CASH USED IN INVESTING ACTIVITIES (6,560) (1,023)
FINANCING ACTIVITIES    
Principal payments on term loans, capital lease obligations and other financing (2,256) (3,708)
Cash proceeds from other financing 2,024
Debt issuance costs (3)
Common stock repurchased to satisfy statutory withholding on employee stock based compensation plans (208) (5)
Common stock repurchased as part of Repurchase Program (1,264)
Cash proceeds from stock plans 68 46
NET CASH USED IN FINANCING ACTIVITIES (375) (4,931)
Net change in cash and cash equivalents (2,616) (1,108)
Cash and cash equivalents, beginning of period 4,318 3,469
Cash and cash equivalents, end of period $ 1,702 $ 2,361